A2B5 Surface ganglioside binding distinguishes between two GFAP-positive clones from a human glioma-derived cell line

8Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A human glioma-derived cell line which expresses both the astrocytic markers, glial fibrillary acidic protein (GFAP) and glutamine synthetase (GS) and cell surface gangliosides recognised by the A2B5 monoclonal antibody has been cloned. Two clones are described, which are A2B5-positive and A2B5-negative, respectively. These neoplastic clones may provide a suitable in vitro model with which to assess the significance of surface ganglioside expression in relation to function and lineage of mammalian glia. © 1990.

Cite

CITATION STYLE

APA

Knott, J. C. A., & Pilkington, G. J. (1990). A2B5 Surface ganglioside binding distinguishes between two GFAP-positive clones from a human glioma-derived cell line. Neuroscience Letters, 118(1), 52–56. https://doi.org/10.1016/0304-3940(90)90247-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free